Radiomics Analysis of (18)F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery

SIMPLE SUMMARY: The estimation of overall survival (OS) in patients with stage III non-small cell lung cancer (NSCLC) is very important for determining a precise therapeutic strategy. Radiomics is a promising method to extract features that can reflect distinct differences in tumor phenotype from im...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jang, Lee, Jaeho, Cheon, Miju, Kim, Hojoong, Choi, Yong Soo, Pyo, Hongryull, Ahn, Myung-Ju, Choi, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093358/
https://www.ncbi.nlm.nih.gov/pubmed/37046673
http://dx.doi.org/10.3390/cancers15072012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093358/
https://www.ncbi.nlm.nih.gov/pubmed/37046673
http://dx.doi.org/10.3390/cancers15072012

Ejemplares similares